Skip to main
TBI
TBI logo

TrueBlue (TBI) Stock Forecast & Price Target

TrueBlue (TBI) Analyst Ratings

Based on 1 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

TrueBlue Inc. reported a 2% year-over-year revenue increase, primarily driven by its commercial staffing segment, which experienced double-digit growth, indicating a strong demand for its services. The company's strategic cost actions led to a notable improvement in adjusted EBITDA margin, which rose by 50 basis points to 0.7%, aligning with forecasts and showcasing enhanced operational efficiency. Despite the revenue being slightly below guidance, the overall growth trends and improved profitability metrics provide a solid foundation for a favorable outlook on the company's financial performance.

Bears say

TrueBlue Inc's financial outlook is negatively impacted by a significant decline in adjusted EBITDA margin, which decreased by 320 basis points year-over-year to 5.2%, indicating lower operating leverage due to a drop in organic revenues. The PeopleReady segment, which is the largest revenue contributor for the company, experienced a year-over-year revenue decline of 5%, surpassing the anticipated decrease of 3%, reflecting ongoing softness across various client verticals. Additionally, the company reported an adjusted loss per share of $(0.07) for the second quarter of 2025, further underscoring challenges in maintaining profitability.

TrueBlue (TBI) has been analyzed by 1 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of TrueBlue and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About TrueBlue (TBI) Forecast

Analysts have given TrueBlue (TBI) a Buy based on their latest research and market trends.

According to 1 analysts, TrueBlue (TBI) has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

TrueBlue (TBI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.